Ocular Pharmacokinetics Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Ocular Pharmacokinetics. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Ocular Pharmacokinetics Indian Medical PG Question 1: Ocular effects that include mydriasis are characteristic of which of the following drugs?
- A. phenylephrine (alpha agonist) (Correct Answer)
- B. neostigmine (cholinesterase inhibitor)
- C. phentolamine (alpha blocker)
- D. mecamylamine (ganglionic blocker)
Ocular Pharmacokinetics Explanation: ***phenylephrine (alpha agonist)***
- **Phenylephrine** is a direct-acting **alpha-1 adrenergic agonist** that causes contraction of the **pupillary dilator muscle**, leading to **mydriasis** (pupil dilation). [1]
- It is frequently used clinically to dilate pupils for **ophthalmologic examinations** due to its selective action on alpha-1 receptors in the eye. [2]
*neostigmine (cholinesterase inhibitor)*
- **Neostigmine** inhibits acetylcholinesterase, increasing acetylcholine at the neuromuscular junction and muscarinic receptors. This leads to **miosis** (pupil constriction), not mydriasis.
- Its ophthalmic use is primarily for treating **glaucoma** by improving aqueous humor outflow through cholinergic effects on the ciliary muscle.
*phentolamine (alpha blocker)*
- **Phentolamine** is a **non-selective alpha-adrenergic antagonist** that blocks both alpha-1 and alpha-2 receptors.
- Alpha-1 receptor blockade in the eye would relax the pupillary dilator muscle, leading to **miosis** or prevention of mydriasis, not its induction.
*mecamylamine (ganglionic blocker)*
- **Mecamylamine** is a **ganglionic blocker** that antagonizes nicotinic receptors in both sympathetic and parasympathetic ganglia.
- Blocking parasympathetic ganglia can cause some mydriasis, but ganglionic blockers have widespread, non-selective autonomic effects and are not primarily used for isolated mydriasis.
Ocular Pharmacokinetics Indian Medical PG Question 2: Which route is most preferred for Endophthalmitis treatment?
- A. Oral antibiotic
- B. Intravenous antibiotic
- C. Topical antibiotic
- D. Intravitreal antibiotic (Correct Answer)
Ocular Pharmacokinetics Explanation: ***Intravitreal antibiotic***
- **Intravitreal injection** directly delivers a high concentration of antibiotics into the **vitreous cavity**, which is essential for treating intraocular infections like endophthalmitis.
- This route bypasses protective barriers like the **blood-retinal barrier**, ensuring therapeutic drug levels reach the infection site promptly and effectively.
*Oral antibiotic*
- **Oral antibiotics** have poor penetration into the **vitreous humor** due to the **blood-retinal barrier**, making them generally ineffective as a sole therapy for endophthalmitis.
- They may be used as an adjunct in some cases but cannot achieve the high local concentrations needed to resolve severe intraocular infections.
*Intravenous antibiotic*
- Similar to oral antibiotics, **intravenous antibiotics** struggle to penetrate the **blood-retinal barrier** adequately to achieve therapeutic concentrations in the vitreous humor for endophthalmitis.
- While they can be administered in severe cases, they do not provide the direct, high-dose delivery needed to control the infection within the eye as effectively as intravitreal injections.
*Topical antibiotic*
- **Topical antibiotics** primarily reach the ocular surface and anterior segment of the eye, with very limited penetration into the **vitreous cavity**.
- They are generally ineffective for treating endophthalmitis, which is an infection of the inner eye, and are typically reserved for superficial ocular infections.
Ocular Pharmacokinetics Indian Medical PG Question 3: What is the mechanism of metabolism for alcohol, aspirin, and phenytoin at high doses?
- A. First pass kinetics
- B. First order kinetics
- C. Zero order kinetics (Correct Answer)
- D. Second order kinetics
Ocular Pharmacokinetics Explanation: ***Zero order kinetics***
- This mechanism occurs when the **metabolic enzymes become saturated at high drug concentrations**, leading to a constant amount (not a constant percentage) of drug being eliminated per unit time.
- Alcohol, aspirin, and phenytoin are examples of drugs that exhibit **saturable metabolism**, transitioning from first-order to zero-order kinetics at higher doses.
*First pass kinetics*
- This describes the **metabolism of a drug by the liver or gut wall enzymes before it reaches systemic circulation** after oral administration.
- While relevant to the oral bioavailability of these drugs, it does not describe the specific mechanism of elimination at high doses.
*First order kinetics*
- In this mechanism, a **constant fraction or percentage of the drug is eliminated per unit of time**, meaning the rate of elimination is directly proportional to the drug concentration.
- Most drugs follow first-order kinetics at therapeutic doses because metabolizing enzymes are not saturated.
*Second order kinetics*
- This is a **less common pharmacokinetic model** where the rate of elimination is proportional to the square of the drug concentration or involves two reactants.
- It does not typically describe the common elimination patterns of most drugs, including alcohol, aspirin, and phenytoin.
Ocular Pharmacokinetics Indian Medical PG Question 4: Which of the following factors influences the duration of action of a drug?
- A. Bioavailability
- B. Clearance
- C. Rate of elimination
- D. All of the options (Correct Answer)
Ocular Pharmacokinetics Explanation: ***All of the options***
- **Clearance** and **rate of elimination** are the primary determinants of how long a drug stays in the body at therapeutic levels, thus directly influencing its duration of action.
- **Bioavailability** affects the intensity and onset but can influence the perceived duration if subtherapeutic concentrations are achieved.
- The interplay of these pharmacokinetic parameters ultimately determines the drug's therapeutic window and frequency of dosing.
*Clearance*
- **Clearance** is the rate at which the active drug is removed from the body, primarily by the kidneys and liver.
- A higher clearance generally leads to a shorter elimination half-life and a **shorter duration of action**, as the drug is removed more quickly from the systemic circulation.
*Rate of elimination*
- The **rate of elimination** directly dictates how quickly the concentration of a drug in the body decreases over time.
- A faster elimination rate (shorter half-life) means the drug's effects will wear off sooner, resulting in a **shorter duration of action**.
- This is quantified by the elimination rate constant (Kel) and half-life (t½).
*Bioavailability*
- **Bioavailability** refers to the fraction of an administered dose of unchanged drug that reaches the systemic circulation.
- While bioavailability primarily affects the **peak concentration (Cmax)** and **intensity** of drug effect, it can indirectly influence duration.
- If bioavailability is very low, therapeutic concentrations may not be sustained long enough, effectively shortening the **clinically relevant duration of action**.
- However, two drugs with identical elimination rates but different bioavailabilities will have the same elimination half-life and similar duration at therapeutic doses.
Ocular Pharmacokinetics Indian Medical PG Question 5: All of the following drugs cause amorphous whorl like corneal deposits except:
- A. Chlorpromazine
- B. Amiodarone
- C. Chloroquine
- D. Indomethacin (Correct Answer)
Ocular Pharmacokinetics Explanation: ***Indomethacin***
- While indomethacin can cause various ocular side effects, **corneal deposits** are not typically described as the **amorphous whorl-like type** seen with the other listed drugs.
- Ocular side effects of indomethacin more commonly include **corneal opacities** and **retinal changes** but not the specific **"cornea verticillata"** pattern.
*Chlorpromazine*
- **Chlorpromazine** can cause **corneal and lenticular deposits**, but these are typically described as **fine granular or stellate deposits** rather than the classic whorl pattern.
- While these deposits can accumulate in the corneal epithelium, they do not characteristically present with the **"cornea verticillata"** (whorl keratopathy) pattern seen with amiodarone and chloroquine.
- The deposits are generally benign but can lead to visual disturbances.
*Amiodarone*
- **Amiodarone** is a classic cause of **cornea verticillata**, or **whorl keratopathy**, with amorphous, whorl-like deposits in the corneal epithelium.
- These deposits occur in **>90% of patients** on long-term therapy and are typically benign and rarely affect vision.
- The whorl pattern is highly characteristic and reversible upon drug discontinuation.
*Chloroquine*
- **Chloroquine** (and hydroxychloroquine) commonly causes **corneal deposits** known as **cornea verticillata**, which appear as gray-brown, whorl-like opacities in the corneal epithelium.
- While these deposits are usually asymptomatic, high doses or prolonged use can lead to visual blurring or halos.
- The whorl pattern is a characteristic finding with this class of drugs.
Ocular Pharmacokinetics Indian Medical PG Question 6: Avascular coat in eye is:
- A. Choroid
- B. Retina
- C. Sclera
- D. Cornea (Correct Answer)
Ocular Pharmacokinetics Explanation: ***Cornea***
- The **cornea** is the transparent, avascular (lacking blood vessels) front part of the eye that covers the iris, pupil, and anterior chamber [1].
- Its avascular nature is crucial for maintaining its **transparency**, essential for light transmission to the retina [1].
*Choroid*
- The **choroid** is a highly vascular layer of the eye, rich in blood vessels, located between the retina and the sclera [1].
- Its primary function is to provide **oxygen and nutrients** to the outer layers of the retina [1].
*Retina*
- The **retina** is the light-sensitive layer at the back of the eye, which contains photoreceptor cells [1].
- While it has its own blood supply (retinal vessels), it is not considered an avascular coat; it actively consumes high amounts of **oxygen and nutrients** [1].
*Sclera*
- The **sclera**, or the white outer layer of the eyeball, is relatively avascular compared to the choroid, but it does contain some blood vessels, particularly in its superficial layers [1].
- Its primary role is to provide **structural support** and protection to the inner components of the eye [1].
Ocular Pharmacokinetics Indian Medical PG Question 7: In ophthalmology, if a patient is allergic to aminoesters, which local anesthetic can be safely used?
- A. Procaine
- B. Cocaine
- C. Prilocaine (Correct Answer)
- D. Tetracaine
Ocular Pharmacokinetics Explanation: **Local anesthetics are classified into two chemical groups: esters (aminoesters) and amides. Allergies to esters typically do not cross-react with amides.**
***Prilocaine***
- **Prilocaine** is an **amide-type local anesthetic**, and allergies to **aminoesters** typically do not cross-react with **amides**.
- It is a safe alternative in patients with a known allergy to **ester-type local anesthetics**.
*Cocaine*
- **Cocaine** is an **ester-type local anesthetic**, sharing a similar chemical structure with **aminoesters**.
- Patients allergic to **aminoesters** are likely to experience a **cross-reaction** with **cocaine**.
*Procaine*
- **Procaine** is a classic **ester-type local anesthetic** (an aminoester).
- An allergy to aminoesters directly implies an allergy to **procaine** due to its chemical classification.
*Tetracaine*
- **Tetracaine** is also an **ester-type local anesthetic** (an aminoester).
- It is contraindicated in patients with an allergy to **aminoesters** due to the high risk of **allergic reaction**.
Ocular Pharmacokinetics Indian Medical PG Question 8: Which of the following is a true statement regarding the human eye?
- A. Lens will not reflect light
- B. Even after cataract surgery UV rays do not penetrate
- C. Normal eye medium will permit wavelengths of 400-700 nm (Correct Answer)
- D. Cornea cuts off wavelengths up to 400 nm
Ocular Pharmacokinetics Explanation: ***Normal eye medium will permit wavelength of 400- 700 nm***
- The **normal human eye** can perceive light in the **visible spectrum**, which ranges approximately from **400 nm (violet)** to **700 nm (red)**.
- This range of wavelengths is efficiently transmitted through the ocular media (cornea, aqueous humor, lens, vitreous humor) to reach the retina.
*Lens will not reflect light*
- The human **lens** does **reflect some light**, contributing to phenomena like **glare** and internal reflections, especially if there are opacities like cataracts.
- While its primary function is to transmit and refract light, it is not perfectly non-reflective.
*Even after cataract surgery UV rays are not penetrated*
- Modern **intraocular lenses (IOLs)** implanted during **cataract surgery** are designed to **block UV light (UVA and UVB)** to protect the retina.
- However, the natural lens also blocks UV light, and before the development of UV-blocking IOLs, patients sometimes experienced increased retinal exposure to UV post-surgery.
*Cornea cut off wavelength upto 400 nm*
- The **cornea** primarily absorbs and blocks **UVB (280-315 nm)** and **UVC (100-280 nm)** radiation, protecting the anterior segment structures and retina from harmful short-wavelength light.
- It does **not cut off wavelengths up to 400 nm**; it primarily transmits wavelengths longer than approximately 300-310 nm into the eye.
Ocular Pharmacokinetics Indian Medical PG Question 9: What is the first-line treatment for acute angle closure glaucoma?
- A. Pilocarpine
- B. Beta blocker eyedrops
- C. IV mannitol
- D. Acetazolamide (Correct Answer)
Ocular Pharmacokinetics Explanation: **Acetazolamide**
- **Acetazolamide** (oral or intravenous) is a carbonic anhydrase inhibitor that rapidly reduces intraocular pressure by decreasing aqueous humor production, making it the **first-line medical treatment** for acute angle-closure glaucoma.
- While other agents are used, acetazolamide provides the quickest and most significant initial reduction in **intraocular pressure (IOP)**, which is crucial in preventing permanent vision loss.
*IV mannitol*
- **Intravenous mannitol** is an osmotic diuretic used to draw fluid from the vitreous humor to lower **IOP** significantly, but it is typically reserved for cases where **acetazolamide** alone is insufficient or for very high **IOPs**.
- It is often considered a second-line or adjunctive agent rather than the initial first-line treatment.
*Pilocarpine*
- **Pilocarpine** is a miotic agent that constricts the pupil, which helps to pull the iris away from the trabecular meshwork and open the angle.
- However, it should only be administered *after* the **intraocular pressure** has been significantly lowered (e.g., with acetazolamide), as it can worsen angle closure in an inflamed eye with very high **IOP**.
*Beta blocker eyedrops*
- **Topical beta-blockers** (e.g., timolol) reduce **IOP** by decreasing aqueous humor production and are a common treatment for various types of glaucoma.
- While useful in acute angle-closure glaucoma, they act more slowly than **acetazolamide** and are typically used as an adjunct rather than the sole initial first-line treatment.
Ocular Pharmacokinetics Indian Medical PG Question 10: Dalen-Fuchs nodules are seen in which of the following?
- A. Retinal detachment
- B. Spring catarrh
- C. Sympathetic ophthalmitis (Correct Answer)
- D. Vogt-Koyanagi-Harada disease
Ocular Pharmacokinetics Explanation: ***Sympathetic ophthalmitis***
- **Dalen-Fuchs nodules** are characterized by accumulations of **lymphocytes, epithelioid cells, and pigment** in the choroid, specifically between Bruch's membrane and the retinal pigment epithelium.
- They are a **pathognomonic sign** of sympathetic ophthalmitis, an autoimmune inflammatory reaction in the contralateral eye after penetrating trauma or surgery to the other eye.
- These nodules represent a **granulomatous inflammatory response** and are a key histopathological finding.
*Retinal detachment*
- This condition involves the **separation of the neurosensory retina** from the underlying retinal pigment epithelium.
- It is typically characterized by symptoms such as **flashes of light, floaters**, and a **darkening peripheral visual field**, rather than specific nodular formations in the choroid.
*Spring catarrh*
- Also known as **vernal keratoconjunctivitis**, this is a severe, chronic, bilateral inflammation of the conjunctiva, primarily affecting children and young adults, often with a history of atopy.
- Its characteristic features include **papillae on the upper tarsal conjunctiva** and **Trantas dots** (collections of eosinophils and epithelial cells) at the limbus, not Dalen-Fuchs nodules.
*Vogt-Koyanagi-Harada disease*
- While VKH disease can also show Dalen-Fuchs nodules as it shares similar granulomatous uveitis features, it is a **distinct bilateral panuveitis** with systemic manifestations including **poliosis, vitiligo, dysacusia, and meningismus**.
- The key differentiating factor is that **sympathetic ophthalmitis requires prior trauma or surgery to one eye**, whereas VKH disease has no such requirement and presents with characteristic extraocular manifestations.
More Ocular Pharmacokinetics Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
